Failure of neuroprotection by embryonic striatal grafts in a double lesion rat model of striatonigral degeneration (multiple system atrophy)

Experimental Neurology

Volumn 164, Issue 1, 2000, Pages 166-175

  Puschban, Zoe ^a,b   Waldner, Regina ^a   Seppi, Klaus ^a   Stefanova, Nadia ^a,c   Humpel, Christian ^a   Scherfler, Christoph ^a   Levivier, Marc ^b   Poewe, Werner ^a   Wenning, Gregor K ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b ERASME HOSPITAL   (Belgium)

^c MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Dopamine D1 and D2 receptors; Dopamine reuptake sites; Embryonic striatal grafts; Glial activation; Multiple system atrophy; Neuroprotection; Striatonigral degeneration

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; BENZODIAZEPINE RECEPTOR; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; EXCITOTOXIN; MAZINDOL; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; OXIDOPAMINE; QUINOLINIC ACID; SPIPERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN GRAFT; CELL SUSPENSION; CIRCLING BEHAVIOR; CONTROLLED STUDY; DOPAMINE UPTAKE; EMBRYO; GLIOSIS; MALE; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT; SHY DRAGER SYNDROME; STRIATE CORTEX;

EID: 0033928934     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7422     Document Type: Article

References (42)

1. 3H]PK 11195 binding autoradiography. Exp. Neurol. 109:1990;333-341.
2. Barker R., Dunnett S. B. Ibotenic acid lesions of the striatum reduce drug-induced rotation in the 6-hydroxydopamine-lesioned rat. Exp. Brain Res. 101:1994;365-374.
3. Ben-Shlomo Y., Wenning G. K., Tison F., Quinn N. P. Survival of patients with pathologically proven multiple system atrophy: A meta-analysis. Neurology. 48:1997;384-393.
4. Bjorklund A., Stenevi U., Schmidt R. H., Dunnett S. B., Gage F. H. Intracerebral grafting of neuronal cell suspensions. I. Introduction and general methods of preparation. Acta Physiol. Scand. Suppl. 522:1983;1-7.
5. Blunt S., Jenner P., Marsden C. D. Autoradiographic study of striatal D1 and D2 dopamine receptors in 6-OHDA-lesioned rats receiving foetal ventral mesencephalic grafts and chronic treatment with L-dopa and carbidopa. Brain Res. 582:1992;299-311.
6. Clarkson E. D., Zawada W. M., Adams F. S., Bell K. P., Freed C. R. Strands of embryonic mesencephalic tissue show greater dopamine neuron survival and better behavioral improvement than cell suspensions after transplantation in parkinsonian rats. Brain Res. 806:1998;60-68.
7. Clemens J. A., Phebus L. A. Dopamine depletion protects striatal neurons from ischemia-induced cell death. Life Sci. 42:1988;707-713.
8. Collins F., Crutcher K. A. Neurotrophic activity in the adult rat hippocampal formation: Regional distribution and increase after septal lesion. J. Neurosci. 5:1985;2809-2814.
9. Deacon T. W., Pakzaban P., Isacson O. The lateral ganglionic eminence is the origin of cells committed to striatal phenotypes: Neural transplantation and developmental evidence. Brain Res. 668:1994;211-219.
10. Dickson D. W., Liu W., Hardy J., Farrer M., Mehta N., Uitti R., Mark M., Zimmerman T., Golbe L., Sage J., Sima A., D'Amato C., Albin R., Gilman S., Yen S. Widespread alterations of alpha-synuclein in multiple system atrophy. Am. J. Pathol. 155:1999;1241-1251.
11. Fearnley J. M., Lees A. J. Striatonigral degeneration. A clinicopathological study. Brain. 113:1990;1823-1842.
12. Foster A. C., Collins J. F., Schwarcz R. On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compounds. Neuropharmacology. 22:1983;1331-1342.
13. Fricker R. A., Torres E. M., Dunnett S. B. The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. I. Morphological characteristics. Neuroscience. 79:1997;695-710.
14. Gilman S., Low P. A., Quinn N., Albanese A., Ben Y., Fowler C. J., Kaufmann H., Klockgether T., Lang A. E., Lantos P. L., Litvan I., Mathias C. J., Oliver E., Robertson D., Schatz I., Wenning G. K. Consensus statement on the diagnosis of multiple system atrophy. J. Auton. Nerv. Syst. 74:1998;189-192.
15. Globus M. Y., Ginsberg M. D., Dietrich W. D., Busto R., Scheinberg P. Substantia nigra lesion protects against ischemic damage in the striatum. Neurosci. Lett. 80:1987;251-256.
16. Grasbon-Frodl E. M., Nakao N., Lindvall O., Brundin P. Developmental features of human striatal tissue transplanted in a rat model of Huntington's disease. Neurobiol. Dis. 3:1997;299-311.
17. Hefti F., Melamed E., Wurtman R. J. Partial lesions of the dopaminergic nigrostriatal system in rat brain: Biochemical characterization. Brain Res. 195:1980;123-137.
18. Kerkerian L., Dusticier N., Nieoullon A. Modulatory effect of dopamine on high-affinity glutamate uptake in the rat striatum. J. Neurochem. 48:1987;1301-1306.
19. Labandeira-Garcia J. L., Wictorin K., Cunningham E. T. J., Bjorklund A. Development of intrastriatal striatal grafts and their afferent innervation from the host. Neuroscience. 42:1991;407-426.
20. Levivier M., Gash D. M., Przedborski S. Time course of the neuroprotective effect of transplantation on quinolinic acid-induced lesions of the striatum. Neuroscience. 69:1995;43-50.
21. Levivier M., Przedborski S. Quinolinic acid-induced lesions of the rat striatum: quantitative autoradiographic binding assessment. Neurol. Res. 20:1998;46-56.
22. Nakao N., Brundin P. Effects of alpha-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid. Neuroscience. 76:1997;749-761.
23. Nakao N., Grasbon-Frodl E. M., Widner H., Brundin P. DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease. Neuroscience. 74:1996;959-970.
24. Nieto-Sampedro M., Lewis E. R., Cotman C. W., Manthorpe M., Skaper S. D., Barbin G., Longo F. M., Varon S. Brain injury causes a time-dependent increase in neuronotrophic activity at the lesion site. Science. 217:1982;860-861.
25. Olsson M., Campbell K., Wictorin K., Bjorklund A. Projection neurons in fetal striatal transplants are predominantly derived from the lateral ganglionic eminence. Neuroscience. 69:1995;1169-1182.
26. Pearlman S. H., Levivier M., Collier T. J., Sladek J. R. J., Gash D. M. Striatal implants protect the host striatum against quinolinic acid toxicity. Exp. Brain Res. 84:1991;303-310.
27. Pezzoli G., Fahn S., Dwork A., Truong D. D., De Yebenes J. G., Jackson-Lewis V., Herbert J., Cadet J. L. Non-chromaffin tissue plus nerve growth factor reduces experimental parkinsonism in aged rats. Brain Res. 459:1988;398-403.
28. Plunkett R. J., Bankiewicz K. S., Cummins A. C., Miletich R. S., Schwartz J. P., Oldfield E. H. Long-term evaluation of hemiparkinsonian monkeys after adrenal autografting or cavitation alone. J. Neurosurg. 73:1990;918-926.
29. Przedborski S., Kostic V., Jackson-Lewis V., Cadet J. L., Burke R. E. Effect of unilateral perinatal hypoxic-ischemic brain injury in the rat on dopamine D1 and D2 receptors and uptake sites: A quantitative autoradiographic study. J. Neurochem. 57:1991;1951-1961.
30. Przedborski S., Levivier M., Kostic V., Jackson-Lewis V., Dollison A., Gash D. M., Fahn S., Cadet J. L. Sham transplantation protects against 6-hydroxydopamine-induced dopaminergic toxicity in rats: behavioral and morphological evidence. Brain Res. 550:1991;231-238.
31. Puschban Z., Scherfler C., Granata R., Laboyrie P., Quinn N. P., Jenner P., Poewe W., Wenning G. K. Autoradiographic study of striatal dopamine reuptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts. Neuroscience. 95:2000;377-388.
32. Scherfler C., Wenning G. K., Puschban Z., Weiler B., Poewe W. Striatal Neuroprotection in a Double Lesion Animal Model of Striatonigral Degeneration. J. Neural Transm. Suppl. 106:1999;XXIX.
33. Sirinathsinghji, D. 1991. Lesioning of rat nigrostriatal dopamine pathway with 1-methyl-4-phenylpyridinium ion (MPP+) In Methods in Neurosciences (P. M. Conn, Ed.), pp. 3-15. Academic Press, San Diego.
34. Stone T. W., Connick J. H., Winn P., Hastings M. H. G., English M. Endogenous excitotoxic agents. Ciba Found. Symp. 126:1987;204-220.
35. Stromberg I., Bjorklund H., Dahl D., Jonsson G., Sundstrom E., Olson L. Astrocyte responses to dopaminergic denervations by 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as evidenced by glial fibrillary acidic protein immunohistochemistry. Brain Res. Bull. 17:1986;225-236.
36. Tison F., Wenning G. W., Daniel S. E., Quinn N. P. The pathophysiology of parkinsonism in multiple system atrophy. Eur. J. Neurol. 2:1995;435-444.
37. Watts C., Caldwell M. A., Dunnett S. B. The development of intracerebral cell-suspension implants is influenced by the grafting medium. Cell Transplant. 7:1998;573-583.
38. Wenning, G. K, F. Tison, C. Scherfler, Z. Puschban, R. Waldner, R. Granata, I. Gorayeb, and, W. Poewe, Towards Neurotransplantation in multiple system atrophy: Clinical rational, pathophysiological basis and preliminary experimental evidence, Cell Transplant. in press.
39. Wenning G. K., Ben-Shlomo Y., Magalhaes M., Daniel S. E., Quinn N. P. Clinicopathological study of 35 cases of multiple system atrophy. J. Neurol. Neurosurg. Psychiatry. 58:1995;160-166.
40. Wenning G. K., Granata R., Laboyrie P. M., Quinn N. P., Jenner P., Marsden C. D. Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration. Mov. Disord. 11:1996;522-532.
41. Wenning G. K., Granata R., Puschban Z., Scherfler C., Poewe W. Neural transplantation in animal models of multiple system atrophy: A review. J. Neural Transm. Suppl. 55:1999;103-113.
42. Whetsell W. O. J., Schwarcz R. Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci. Lett. 97:1989;271-275.